This webinar will provide insight into microfluidic technologies and hybrid solutions that have an enormous impact on the progress in science and healthcare. Microfluidics enables the automation and integration of complex operations on-chip, with reduced sample and reagent volumes. This webinar will focus on how microfluidic technologies have driven progress in in vitro diagnostics, with a tremendous impact on the way healthcare is delivered to the public, through decentralization. Several market and technology trends will be presented and the use of microfluidic technologies in the rapidly growing field of Point-of-Care diagnostics will be further discussed.
Monica Brivio is Senior Strategy & Business Development Manager of the BioMedical unit of Micronit. Monica joined the company in 2012 as an R&D Project Manager and later Strategic R&D Manager. As a former Assistant Professor at the Technical University of Denmark and leading researcher at both Uppsala University (Uppsala, Sweden) and the Science for Life Laboratory (Stockholm, Sweden), Monica has many years of experience in the field of lab-on-a-chip technologies and microfluidics for applications in chemistry and life science. She received her Ph.D. degree in Chemical Engineering at the University of Twente (Enschede, The Netherlands) in 2005.